Analysis of Therapeutic Effect of Mifepristoneon and Megestrol Acetate Niagestin on Dysfunctional Uterine Bleeding during Perimenopausal Period
Shuzeng Zhang
Abstract
Shuzeng Zhang
Abstract
Objective To evaluate the clinical effects of Mifepristone versus Megestrol Acetate Niagestin in treatment of patients with perimenopausal dysfunctional uterine bleeding.Methods Eighty patients were randomly divided into the experimental group(Mifepristone) and the control group(Megestrol Acetate Niagestin).The thickness of endometrium and level of hormone were observed for the experimental group.Results The experimental group had better effects than those in the control group(P0.05).FSH、LH、E2、P serum levels decreasing is statistically significant and endometrium were thinner(P0.05,P0.01).Conclusion Treatment of dysfunctional uterine bleeding during perimenopausal period with mifepristone is a safe and validi method.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the clinical effects of Mifepristone versus Megestrol Acetate Niagestin in treatment of patients with perimenopausal dysfunctional uterine bleeding.Methods Eighty patients were randomly divided into the experimental group(Mifepristone) and the control group(Megestrol Acetate Niagestin).The thickness of endometrium and level of hormone were observed for the experimental group.Results The experimental group had better effects than those in the control group(P0.05).FSH、LH、E2、P serum levels decreasing is statistically significant and endometrium were thinner(P0.05,P0.01).Conclusion Treatment of dysfunctional uterine bleeding during perimenopausal period with mifepristone is a safe and validi method.
Key concepts: Megestrol acetate, Mifepristone, Dysfunctional uterine bleeding, Megestrol, Medicine, Endometrium, Gynecology, Cyproterone acetate